A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling

International Immunology

Volumn 21, Issue 10, 2009, Pages 1135-1144

  Ju, Songwen ^a,b   Ju, Songguang ^a   Ge, Yan ^a   Qiu, Hongxia ^b   Lu, Binfeng ^c   Qiu, Yuhua ^a   Fu, Jingxiang ^a   Liu, Gaoqin ^a   Wang, Qin ^a   Hu, Yumin ^a   Shu, Yongqian ^b   Zhang, Xueguang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

4 1BBL; Co stimulatory molecule; Dendritic cells; Monocytes; Reverse signaling

Indexed keywords

CD137 LIGAND; CD83 ANTIGEN; CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS MIXED LYMPHOCYTE REACTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; REVERSE SIGNALING; SIGNAL TRANSDUCTION; TH1 CELL;

4-1BB LIGAND; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MONOCYTES; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349506614     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp077     Document Type: Article

References (50)

1. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Steinman, R. M., Turley, S., Mellman, I. et al. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411.
3. Romani, N., Gruner, S., Brang, D. et al. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
4. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109.
5. Caux, C., Sealand, S., Favre, C. et al. 1990. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 75: 2292.
6. Rosenzwajg, M., Canque, B. and Gluckman, J. C. 1996. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 87:535.
7. Strunk, D., Rappersberger, K., Egger, C. et al. 1996. Generation of human dendritic cells/langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 87:1292.
8. Thurnher, M., Papesh, C., Ramone, R. et al. 1997. In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. Exp. Hematol. 25:232.
9. Szabolcs, P., Avigan, D., Gezelter, S. et al. 1996. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87:4520.
10. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. et al. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160:4587.
11. Cella, M., Scheidegger, D., Palmer-Lehmann, K. et al. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
12. Snijders, A., Kalinski, P., Hilkens, C. M. et al. 1998. High level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593.
13. Ito, T., Amakawa, R., Inaba, M. et al. 2001. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166:2961.
14. Noelle, R. 1996. CD40 and its ligand in host defense. Immunity 4:415.
15. Sun, M. and Fink, P. J. 2007. A new class of reverse signaling costimulators belongs to the TNF family. J. Immunol. 179:4307.
16. Langstein, J., Michel, J. and Schwarz, H. 1999. CD137 induces proliferation and endomitosis in monocytes. Blood 94:3161.
17. Kienzle, G. and Kempis, J. V. 2000. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int. Immunol. 12:73.
18. Langstein, J. and Schwarz, H. 1999. Identification of CD137 as a potent monocyte survival factor. J. Leukoc. Biol. 65:829.
19. Ju, S. W., Ju, S. G., Wang, F. M. et al. 2003. A functional anti-human 4-1BB ligand monoclonal antibody that enhances proliferation of monocytes by reverse signaling of 4-1BBL. Hybrid. Hybridomics 22:333.
20. Arens, R., Nolte, M. A., Tesselaar, K. et al. 2004. Signaling through CD70 regulates B cell activation and IgG production. J. Immunol. 173:3901.
21. Cerutti, A., Schaffer, A., Goodwin, R. G. et al. 2000. Engagement of CD153 (CD30 ligand) by CD30 T cells inhibits class switch DNA recombination and antibody production in human IgD1 IgM B cells. J. Immunol. 165:786.
22. Wiley, S. R., Goodwin, R. G. and Smith, C. A. 1996. Reverse signaling via CD30 ligand. J. Immunol. 157:3635.
23. Wenzel, J., Sanzenbacher, R., Ghadimi, M. et al. 2001. Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 509:255.
24. Suzuki, I. and Fink, P. J. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
25. Stüber, E., Neurath, M., Calderhead, D. et al. 1995. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2:507.
26. Cannons, J. L., Lau, P., Ghumman, B. et al. 2001. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167:1313.
27. Wen, T., Bukczynski, J. and Watt, T. H. 2002. 4-1BB ligandmediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol. 168:4897.
28. Bertram, E. M., Lau, P. and Watts, T. H. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 168:3777.
29. Ohshima, Y., Tanaka, Y., Tozawa, H. et al. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159:3838.
30. Munn, D. H., Sharma, M. D. and Mellor, A. L. 2004. Ligation of B7-1/B7-2 by human CD4 T cells triggers indoleamine 2, 3-dioxygenase activity in dendritic cells. J. Immunol. 172:4100.
31. Maraskovsky, E., Brasel, K., Teepe, M. et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in FLT3-ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
32. Brasel, K., McKenna, H. J., Morrissey, P. J. et al. 1996. Hematologic effects of FLT3-ligand in vivo in mice. Blood 88.
33. Shurin, M. R., Pandharipande, P. P., Zorina, T. D. et al. 1997. FLT3ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol. 179:174.
34. Pulendran, B., Smith, J. L., Jenkins, M. et al. 1998. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J. Exp. Med. 188:2075.
35. Pulendran, B., Banchereau, J., Burkeholder, S. et al. 2000. Flt3ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165:566.
36. Latchman, Y. E., Liang, S. C., Wu, Y. et al. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl Acad. Sci. USA 101:10691.
37. Keir, M. E., Liang, S. C., Guleria, I. et al. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203:883.
38. Lotz, M., Jirik, F., Kabouridis, P. et al. 1988. B cell stimulating factor interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167:1253.
39. Stein, P. H. and Singer, A. 1992. Similar co-stimulation requirements of CD4+ and CD8+ primary T helper cells: Role of IL-I and IL-6 in inducing IL-2 secretion and subsequent proliferation. Int. Immunol. 4:327.
40. Heufler, C., Koch, F., Stanzl, U. et al. 1996. Interleukin-12 produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T-helper 1 cells. Eur. J. Immunol. 26:659.
41. Murphy, E. E., Terres, G., Macatonia, S. E. et al. 1994. B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
42. Ijzermans, J. N. and Marquet, R. L. 1989. Interferon-gamma: A review. Immunobiology 179:456.
43. Boehm, U., Klamp, T., Groot, M. et al. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749.
44. Jonuleit, H., Kuhn, U., Muller, G. et al. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135.
45. Colic, M., Mojsilovic, S., Pavlovic, B. et al. 2004. Comparison of two different protocols for the induction of maturation of human dendritic cells in vitro. Vojnosanit. Pregl. 61:471.
46. Caux, C., Massacrier, C., Vanbervliet, B. et al. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6:1177.
47. Buelens, C., Willems, F., Delvaux, A. et al. 1995. IL-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25:2668.
48. Allavena, P., Piemonti, L., Longoni, D. et al. 1998. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28:359.
49. Curiel, T. J., Wei, S., Dong, H. et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9:562.
50. Brown, J. A., Dorfman, D. M., Ma, F. R. et al. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170:1257.